Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 13Unknown 5Recruiting 4Active not recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Breast Neoplasms 1401Neoplasms 1128Prostatic Neoplasms 745Lung Neoplasms 621Colorectal Neoplasms 599Carcinoma, Non-Small-Cell Lung 570Carcinoma, Hepatocellular 414Pancreatic Neoplasms 402Leukemia, Myeloid, Acute 398Stomach Neoplasms 356Multiple Myeloma 326Brain Neoplasms 311Ovarian Neoplasms 310Head and Neck Neoplasms 290Neoplasm Metastasis 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 260Rectal Neoplasms 254Uterine Cervical Neoplasms 248Recurrence 248Melanoma 243Esophageal Neoplasms 237Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Lymphoma 214Sarcoma 209Urinary Bladder Neoplasms 192Colonic Neoplasms 192Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 182

Interventions

Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Patient Acceptance of Health Care × Clear all
NCT07024329 2026-04-30

RESPONd

University of Calgary

Phase NA Recruiting
1,055 enrolled

Neoplasms, Patient Acceptance of Health Care

NCT06326567 2025-04-06

Comprehensive Connected Cancer Care (C4): Intervention Evaluation

University of Kentucky

Phase NA Recruiting
300 enrolled

Neoplasms, Patient Acceptance of Health Care

NCT06436157 2025-01-31

GENESIS

University of California, Davis

Phase NA Recruiting
60 enrolled

Patient Acceptance of Health Care

NCT05248412 2022-03-08

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

The University of Hong Kong

Recruiting
250,000 enrolled

Noncommunicable Diseases, COVID-19, Cardiovascular Diseases, Diabetes Mellitus, Hypertension, Neoplasms, Patient Acceptance of Health Care, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡